Kategorieë
Artikels

Periodieke koorsKindergesondheidLaboratoriuminterpretasie

PFAPA-sindroom kan herhalende hoë koors met mondsere, ’n seer keel en geswelde nekkliere veroorsaak, wat gewoonlik 3–7 dae duur, met volledige herstel tussen aanvalle. Diagnose berus op die herhalende patroon en die uitsluiting van ander oorsake—nie op een abnormale bloedtoets nie. ’n Simptoomdagboek help; ’n buitengewoon ernstige of ander episode vereis ’n nuwe beoordeling.

Gepubliseer 17 min. lees

Belangrike punte

  • PFAPA-sindroom veroorsaak gewoonlik koorsepisodes wat 3–7 dae duur, met verskeie weke van goeie gesondheid tussenin.
  • PFAPA-simptome sluit afteuse mondsere, faringitis en geswelde servikale limfknope in; al 3 kenmerke hoef nie gelyktydig voor te kom nie.
  • Koorspatroon volg dikwels ’n min of meer 2–8-weeklikse siklus, maar presiese gereeldheid volgens die kalender is nie nodig vir diagnose nie.
  • Simptoomdagboeke behoort episodums, die maksimum temperatuur in °C of °F, simptome, medisyne en herstel tussen aanvalle aan te teken.
  • Bloedtoetse kan verhoogde CRP en neutrofiele tydens aanvalle toon; ’n CRP van 80 mg/L onderskei nie PFAPA van infeksie nie.
  • Sikliese neutropenie kan ongeveer elke 21 dae terugkeer en kan herhaalde bloedtellings vereis eerder as ’n enkele gerusstellende CBC.
  • Behandelingsbesluite kan deur ’n klinikus voorgeskrewe kortikosteroïede, voorkomingsmedisyne of ’n mangeloperasie behels; niks hiervan behoort slegs op grond van ’n laboratoriumuitslag te volg nie.
  • Dringende evaluasie is nodig vir enige baba jonger as 3 maande met ’n temperatuur van 38°C of hoër, of enige kind met asemhalingsprobleme, verminderde reaksie of ’n uitslag wat nie verbleik wanneer daarop gedruk word nie.

Wat is PFAPA-sindroom, en wat veroorsaak die koors?

PFAPA-sindroom is ’n outo-inflammatoriese toestand wat herhaalde koorsepisodes met afteuse mondsere, faringitis en servikale adenitis veroorsaak. Aanvalle duur gewoonlik 3–7 dae; kinders keer gewoonlik tussen episodes terug na hul normale energievlakke, eetlus en groei.

PFAPA syndrome illustrated through tonsil anatomy, mouth affected sites and cervical lymph nodes
Bevindinge in die mond, keel en nek kom saam met die herhalende koorspatroon voor.

PFAPA weerspieël onvanpaste aktivering van inflammatoriese weë eerder as ’n nuwe aansteeklike siekte elke paar weke. Aanvang is meestal voor die ouderdom van 5, maar ouer kinders en volwassenes kan ook geraak word; die historiese ouderdomsgrens is dus ’n leidraad, nie ’n absolute uitsluiting nie (Wang et al., 2021). PFAPA beteken nie dat elke toekomstige koors nie-aansteeklik is nie.

Die akroniem beskryf 4 komponente: periodieke koors, afteuse stomatitis, faringitis en adenitis. Anders as verskeie oorgeërfde periodieke koorstoestande, het PFAPA geen enkele gevestigde genetiese toets wat die diagnose bevestig nie, hoewel familiale groepering kan voorkom; ’n negatiewe breë genetiese paneel bewys nie PFAPA nie en sluit ook nie elke alternatiewe inflammatoriese afwyking uit nie.

Kantesti is 'n KI-bloedtoetsontleder wat kan help verduidelik waarom ’n CRP-uitslag van 80 mg/L kliniese konteks eerder as ’n diagnostiese etiket vereis. Ons organisasie en benadering beskryf die diens, maar om PFAPA te identifiseer, moet ’n klinikus simptome oor verskeie episodes heen met mekaar in verband bring, die kind ondersoek en toestande oorweeg wat ’n laboratoriumverslag nie kan vasstel nie.

Watter PFAPA-simptome maak die patroon herkenbaar?

PFAPA-simptome kombineer gewoonlik koors met ’n seer keel, teer nekklier(e) of klein mondsere. Dieselfde kombinasie wat oor 3 of meer gedokumenteerde episodes herhaal, is meer insiggewend as enige geïsoleerde simptoom, hoewel geen universele minimumaantal episodes PFAPA bevestig nie.

PFAPA syndrome teaching model showing a small inner-lip affected site beside a tonsil model
Klein aangetaste plekke in die mond word saam met keel- en klierbevindinge geïnterpreteer.

Afteuse ulkusse is gewoonlik klein, vlak sere aan die binnekant van die lippe, wange of ander mondoppervlakke—nie dieselfde as gegroepeerde blase aan die buitekant van die lip nie. ’n Kind kan slegs 1 of 2 sere hê, en ulkusse kan tydens sommige aanvalle afwesig wees; om ’n sigbare seer af te neem, kan help wanneer dit verdwyn voordat die afspraak plaasvind.

Faringitis kan rooiheid of ’n bedekking op die mangels insluit, dus kan die voorkoms alleen nie PFAPA van streptokokinfeksie onderskei nie. Geswelde kliere behels gewoonlik die servikale limfknope rondom die nek, terwyl ’n limfknoop wat aanhoudend groter word, algemene klierswelling of simptome wat langer as ’n aanval van 3–7 dae duur, ’n ander verklaring vereis eerder as outomatiese toeskrywing aan PFAPA.

Mondsere alleen is nie ’n diagnose van periodieke koors nie. Herhaalde mondsere wat met genitale sere, pynlike rooi oë, sigveranderinge of ongewone velbevindinge gepaardgaan, dui op ander moontlikhede, insluitend Behçet-simptoompatrone; selfs 1 episode van oogpyn met verswakte sig vereis ’n spoedige beoordeling, sonder om vir nog ’n koorssiklus te wag.

Hoe lank duur PFAPA-koors, en hoe dikwels keer dit terug?

PFAPA-koors duur gewoonlik 3–7 dae en kom ongeveer elke 2–8 weke, terug, dikwels met opvallend soortgelyke simptome. Sommige kinders ontwikkel ’n voorspelbare ritme, maar wisselende tussenposes sluit PFAPA nie outomaties uit nie.

PFAPA syndrome fever cycles represented by alternating warm episode groups and cool recovery gaps
Episodeduur en hersteltydperke bied afsonderlike leidrade oor herhalende koors.

Temperatures during PFAPA attacks often reach 39–40°C, but fever height does not determine the diagnosis or reliably measure danger. The timing of associated throat symptoms, the child's appearance and the return to baseline matter more; measuring temperature with the same method also makes comparisons more useful than alternating between forehead, ear and underarm readings.

For a hypothetical child, fevers beginning on days 1, 29 and 58 with 4-day attacks suggest a repeated cycle—not proof of PFAPA. Count start-to-start intervals separately from fever-free days, and record whether corticosteroid treatment changed an interval; a shortened next cycle after treatment can otherwise make a previously regular pattern look inexplicably irregular.

A fever that does not stop is not a series of separate PFAPA episodes. If symptoms persist beyond 7 days, or recovery never occurs, clinicians reconsider infection and other inflammatory conditions; our explanation of tydsberekening van bloedtoetseffekte also shows why a sample taken on day 1 cannot be interpreted like one taken after recovery.

Wat behoort ’n PFAPA-simptoomdagboek aan te teken?

A PFAPA symptom diary should record episode start and finish dates, measured temperature, mouth and throat findings, neck swelling, medication timing and wellness between attacks. Even 3 carefully documented episodes can reveal details that a single clinic visit misses.

PFAPA syndrome diary preparation with caregiver hands, a thermometer and a numberless episode planner
A structured diary captures attack timing, associated symptoms and complete recovery.

Document the thermometer method and the highest measured temperature, not just 'very hot.' For each day of a 4-day attack, note drinking, urine output, activity, cough, runny nose, abdominal symptoms and whether anyone nearby was ill; these observations distinguish a repeated inflammatory pattern from unrelated respiratory or gastrointestinal illnesses more effectively than recording fever alone.

Medication entries need the name, dose, administration time and observed response. If a prescribed medicine is given at 09:00 and fever settles by 14:00, record that interval without claiming the medicine established PFAPA; include throat swab results and whether a laboratory sample preceded treatment, because both antibiotics and corticosteroids can complicate interpretation of subsequent findings.

Well days deserve entries too. A weekly note of normal appetite, play, school attendance and any lingering symptoms prevents a diary from becoming an attack-only record; when a clinician requests a recovery sample, our voorbereidingsgids vir basislyntoetse explains how to record recent illness and medicines rather than treating a sample 2 days after fever as an unquestionable baseline.

Waarom is dit so belangrik dat ’n mens tussen PFAPA-episodes gesond voel?

Complete wellness between episodes strongly supports a typical PFAPA pattern: normal activity, appetite and growth should return after the 3–7-day attack. Persistent symptoms or continuing inflammation between attacks make clinicians reconsider the diagnosis.

PFAPA syndrome comparison of tonsil and cervical node models during an episode and after recovery
Recovery between attacks is a clinical finding, not merely a temperature change.

A child who is fever-free but remains exhausted, loses weight or develops daily pain has not truly returned to baseline. Growth is assessed through serial height and weight measurements, not 1 percentile in isolation; crossing growth centiles over time may justify investigation even when individual fever episodes resemble PFAPA and routine examinations during attacks look familiar.

Repeated ordinary infections are common in young children, but unusually severe, prolonged or unusual infections suggest a different evaluation. A history of 2 hospital-treated infections or recurrent deep infections matters differently from several mild colds; clinicians consider the organisms, sites, treatment response and family history, as discussed in our guide to toetsing van gereelde infeksies.

Inflammatory markers usually fall toward the laboratory reference range between PFAPA attacks, but an immediately post-fever sample may still reflect recovery. A persistent CRP of 25 mg/L on repeated genuinely well-day samples is not proof of another disease, yet it deserves explanation; a clinician may check for an unnoticed infection, ongoing inflammatory symptoms or a sampling timeline that was mislabeled.

Wat toon CRP, ESR en bloedtellings by PFAPA?

PFAPA attacks can raise CRP, ESR and neutrophil counts, but none of these tests confirms PFAPA or excludes infection. Many laboratories use a CRP upper reference limit around 5 mg/L, terwyl ander gebruik 10 mg/L; the report's own range matters.

PFAPA syndrome laboratory assessment using a CRP assay cuvette and a complete-count sample cartridge
Inflammatory laboratory changes support timing assessment but cannot establish PFAPA.

Consider a hypothetical child with CRP 80 mg/L during fever and 3 mg/L after recovery. That change supports an episodic inflammatory process but does not identify its cause; infection can produce the same pattern, while ESR may normalize more slowly than CRP, making a modestly raised recovery ESR less surprising than persistent symptoms or repeatedly elevated CRP.

White-cell interpretation must use age-appropriate absolute counts rather than adult ranges or percentages alone. At Kantesti, we emphasize that CRP 8 mg/dL equals 80 mg/L—a tenfold unit conversion that can otherwise create a false impression of improvement; our WBC en CRP vergelyking explains why these markers can disagree because they change at different rates.

Procalcitonin is sometimes considered when serious bacterial infection is suspected, but it is not a standalone PFAPA discriminator. A low result, including a value below 0.1 ng/mL, cannot safely overrule a concerning examination or very early illness; the limits described in our prokalsitonien-interpretasiegids matter more than using one reassuring number to justify home treatment.

Hoe stel klinici ’n PFAPA-diagnose?

PFAPA diagnosis is clinical: clinicians identify repeated characteristic attacks, document recovery between them and exclude plausible alternatives. Onset before age 5 supports traditional criteria, but later onset does not prevent a diagnosis when the overall pattern fits.

The diagnostic process usually starts with history and examination rather than an extensive panel of rare-disease tests. Wang et al. (2021) describe the value of stereotyped episodes, absence of typical respiratory symptoms, negative relevant cultures and response to prescribed corticosteroids; however, 1 negative throat swab or 1 rapid response cannot independently establish PFAPA, and classification criteria are not identical to bedside diagnosis.

Streptococcal testing addresses the current throat illness, while an ASO antibody test mainly reflects previous exposure. An ASO result of 400 IU/mL does not prove that today's recurrent fever is active strep infection; age, local reference ranges and symptom timing affect interpretation, as explained in our discussion of ASO and recent exposure.

Kantesti is 'n KI-aangedrewe bloedtoets-analisehulpmiddel that can contextualize laboratory units and repeated results, but 2 matching reports cannot confirm PFAPA. Our tegniese en kliniese toesig information should not be read as validation of a PFAPA diagnostic test; pediatric or rheumatology assessment remains necessary when the pattern is atypical, severe or uncertain.

Hoe word PFAPA van herhaalde infeksies onderskei?

Repeated infections are more likely when episodes follow sick contacts, have varying symptoms or include cough, runny nose, diarrhea or a confirmed pathogen. PFAPA more often repeats a similar 3–7-day pattern with complete wellness between attacks, but the two can coexist.

PFAPA syndrome differential illustrated by a non-specific throat sample with epithelial and immune cells
Throat sample findings require context because microbial detection can be incidental.

A positive respiratory PCR does not always explain the entire fever history. Adenovirus can remain detectable after an illness, so 1 positive result must be matched to current symptoms, examination and timing; our discussion of adenovirusopsporing en -uitskeiding explains why a molecular result may indicate recent exposure rather than the cause of every subsequent attack.

Longer-lasting sore throat, fatigue and gland enlargement can suggest a different illness rather than PFAPA. EBV antibody patterns distinguish recent infection from prior exposure more effectively than a single positive IgG result; our EBV teenliggaam patroon gids explains the roles of 3 commonly reported markers—VCA IgM, VCA IgG and EBNA IgG—without equating past exposure with today's symptoms.

Antibiotic response is also easy to misread. If an antibiotic begins on day 4 and the fever ends on day 5, spontaneous resolution of a PFAPA attack is possible; conversely, a confirmed bacterial infection still requires appropriate treatment, and neither previous PFAPA nor prior antibiotic failure permits a new illness with different symptoms to be dismissed without assessment.

Watter ander periodieke koorsafwykings kan soos PFAPA lyk?

Sikliese neutropenie and inherited autoinflammatory disorders can resemble PFAPA, especially when mouth sores accompany recurring fever. Approximately 21-day cycles, severe infections, marked abdominal or chest pain, unusual rashes or persistent inflammation help clinicians decide which alternatives to investigate.

PFAPA syndrome differential showing neutrophil cellular elements relevant to cyclic neutropenia assessment
Serial neutrophil counts can reveal a cycle that one sample misses.

Cyclic neutropenia can produce recurrent fever, mouth sores and gum problems while a blood count between low-count periods looks normal. When suspected, clinicians may request CBCs 2–3 times weekly for about 6 weeks to identify repeated neutrophil nadirs; an absolute neutrophil count below 0.5 × 10^9/L during fever requires urgent clinical assessment rather than being labeled a routine PFAPA attack.

Familial Mediterranean fever often causes shorter attacks, commonly 12–72 hours, with abdominal or chest pain from serosal inflammation or joint symptoms. Our verduideliking van MEFV-toetsing shows why genotype and symptoms must be interpreted together; TRAPS may produce longer attacks, sometimes over 7 days, while mevalonate kinase deficiency can involve diarrhea, vomiting and attacks triggered by vaccination or other stressors.

Ancestry and family history guide assessment, but neither should become a gatekeeper that excludes an inherited disorder. Persistently raised serum amyloid A between attacks can indicate ongoing inflammation and requires context, as our serum amyloid A guide explains; a single high value during a 4-day fever does not diagnose amyloidosis, and typical PFAPA should not automatically be assigned the complication risks of other syndromes.

Watter koorswaarskuwingstekens vereis dringende beoordeling?

Kry noodhulp for fever with breathing difficulty, reduced responsiveness, a stiff neck, a non-blanching rash or severe dehydration. An infant younger than 3 maande met ’n temperatuur van 38°C of hoër needs urgent medical assessment, even if a family member has PFAPA.

PFAPA syndrome warning-sign illustration showing asymmetric tonsil enlargement and a narrowed throat passage
Asymmetric throat swelling and airway narrowing require assessment beyond routine PFAPA.

Difficulty swallowing saliva, drooling, a muffled voice or marked one-sided throat swelling can indicate an airway-threatening problem rather than a usual PFAPA flare. A child aged 3–6 months with a temperature of 39°C or higher also needs urgent assessment; contact local emergency services for immediate danger instead of waiting for a blood result or an expected fever endpoint.

Fever lasting 5 days or longer warrants prompt medical review, particularly with red eyes, cracked lips, rash or swollen hands and feet. These findings can suggest Kawasaki disease, discussed in our Kawasaki assessment guide; incomplete presentations occur, so clinicians do not require every classic feature, and concerning symptoms should be assessed before day 5 rather than waiting for a threshold.

New severe localized abdominal pain, persistent vomiting or inability to walk normally should not be attributed to PFAPA without examination. Even 1 normal WBC or CRP result cannot reliably exclude an early abdominal emergency, as our appendicitis laboratory limits explain; children with a known fever syndrome can still develop unrelated illnesses, especially when the attack looks different from their established pattern.

Hoe word PFAPA-aanvalle behandel, en wat beteken ’n reaksie op steroïede?

PFAPA attack treatment focuses on comfort, hydration and, when prescribed, corticosteroids that often stop fever within hours. Published prednisone or prednisolone regimens range from 0.5–2 mg/kg, but dosing, maximum dose and eligibility must be set by the treating clinician.

PFAPA syndrome attack monitoring with a non-contact thermometer beside throat and recurrence teaching models
Temperature response is recorded without treating it as a diagnostic test.

Vanoni et al. (2016) describe rapid corticosteroid responses alongside the limitation that treatment may shorten the interval to the next attack. Reports summarized in that review estimated shorter intervals in approximately 25–50% of patients, but these observations come from heterogeneous studies rather than a precise prediction for an individual child; attack control and long-term prevention are separate treatment goals.

For a hypothetical 20-kg child, a clinician-selected dose of 1 mg/kg would equal 20 mg; this calculation illustrates weight-based prescribing, not a home-treatment recommendation. Families need a written plan explaining when a familiar attack qualifies for treatment, when to seek assessment first and what to do if the expected response does not occur—especially if symptoms suggest a new infection.

Antipyretics may improve discomfort even when they do not end the inflammatory episode. Choose child-appropriate preparations with a clinician or pharmacist, avoid aspirin unless specifically prescribed and do not duplicate paracetamol/acetaminophen across 2 products; Kantesti cannot authorize steroid treatment, and our discussion of AI interpretasie by kinders explains why pediatric decisions need more than laboratory pattern recognition.

Wanneer word voorkomende medisyne of ’n mangeloperasie oorweeg?

Prevention or tonsillectomy may be considered when PFAPA attacks repeatedly disrupt daily life or attack treatment is unsatisfactory. A Cochrane review included 2 randomized trials involving 67 children, finding benefit from tonsil surgery while emphasizing the limited size of the evidence base.

PFAPA syndrome surgical-decision model comparing palatine tonsils with a simplified post-removal anatomy
Tonsil removal decisions balance attack burden, diagnostic confidence and procedural risks.

Burton et al. (2019) judged the evidence for several tonsillectomy outcomes to be of moderate certainty, but the trials were too small to characterize uncommon harms confidently. The evidence concerns selected children rather than every person with recurrent sore throat; a child missing 4 school days each month may value potential benefit differently from a child with infrequent, easily managed attacks.

Colchicine is sometimes used to reduce attacks under specialist supervision, whereas cimetidine has less convincing evidence. Treatment selection should consider the diagnosis, kidney and liver function, other medicines and the possibility of an inherited fever disorder; when several options exist, agree in advance on a measurable goal, such as fewer attacks across 3 months, rather than assuming a changed laboratory number demonstrates success.

Tonsillectomy carries postoperative pain, dehydration, anesthesia-related risks and bleeding risk, even when it improves PFAPA. Kantesti's riglyne vir verantwoordelike KI supports a clear boundary: neither 1 elevated inflammatory marker nor an automated report can decide whether surgery is appropriate; that discussion belongs with the treating pediatric team and an ENT specialist who can assess the child's individual risks.

Watter opvolgsorg help kinders, volwassenes en gesinne met PFAPA?

PFAPA follow-up should track attack burden, growth or weight, treatment response and any symptoms between episodes. Many childhood cases improve over several years, but persistence, relapse and adult-onset disease occur; a 3-month review interval can be a practical individualized plan rather than a universal rule.

PFAPA syndrome follow-up with parent and child reviewing a physical episode timeline in a clinic
Follow-up combines episode burden, normal growth and safe handling of records.

Adults require the same attention to repeated patterns and alternative causes, not an assumption that PFAPA is impossible after childhood. Fever with oral sores and pharyngitis can support the diagnosis, but new constitutional symptoms, persistent gland enlargement or abnormal findings between attacks need assessment; a 35-year-old with a first prolonged fever should not self-diagnose PFAPA from an online symptom match.

Prepare a concise appointment summary: attack dates, duration, associated features, well-day symptoms, test results and response to prescribed treatment. Include 1 clearly labeled attack sample and any clinician-requested recovery sample, rather than ordering a broad panel every month; repeated testing is useful only when it answers a specific question, such as whether inflammation persists or neutrophil counts cycle.

Kantesti is 'n AI bloedtoets interpretasie platform that can help explain uploaded CBC and inflammatory-marker reports alongside their dates, units and stated reference ranges. For a family sharing 2 or more records, check each person's identity and consent before upload, and review our privaatheid- en dataverwerking; AI explanation does not replace pediatric examination, urgent triage or a specialist diagnosis.

Navorsingspublikasies: bewyse teenoor agtergrondgidse vir laboratoriumtoetse

PFAPA evidence comes from clinical descriptions, differential-diagnosis research and treatment studies—not from a specific clotting or serum-protein test. The 2 background publications below explain other laboratory topics and should not be mistaken for studies validating PFAPA diagnosis.

PFAPA syndrome research diorama showing tonsil tissue, liver protein response and non-specific fever signaling
General inflammatory pathways do not establish a specific PFAPA laboratory signature.

The peer-reviewed PFAPA review by Wang et al. (2021), treatment review by Vanoni et al. (2016) and Cochrane analysis by Burton et al. (2019) directly inform this article's clinical discussion. The surgical review's 67-child evidence base illustrates why certainty must be proportionate to study size; a named source supports a specific claim, not every recommendation made elsewhere on the page.

Kantesti se clotting test background guide en serumproteïen-agtergrondgids accompany the 2 Zenodo records listed below. Neither aPTT nor an albumin/globulin ratio confirms PFAPA, and neither guide establishes that routine testing of those markers improves PFAPA care; additional tests should follow an identified clinical concern rather than the availability of a panel.

Evidence interpretation should distinguish a repository-hosted educational guide from a peer-reviewed condition-specific study or systematic review. Our standaarde vir mediese inhoud explain the editorial approach; for a child with 3 apparently similar attacks, the practical priority remains documented recovery, targeted exclusion of alternatives and a clear safety plan, not accumulating more citations or tests that do not answer the clinical question.

Dikwels gevraagde vrae

Wat is PFAPA-sindroom?

PFAPA-sindroom is ’n outoinflammatoriese toestand wat herhalende koors met afteuse mondsere, faringitis en geswelde servikale limfkliere veroorsaak. Episodes duur gewoonlik 3–7 dae en kom elke paar weke terug, met normale gesondheid tussen aanvalle. Die toestand begin gewoonlik voor die ouderdom van 5, hoewel ouer kinders en volwassenes ook aangetas kan word. Geen enkele bloedtoets bevestig PFAPA nie; die diagnose berus dus op die herhalende kliniese patroon en beoordeling vir alternatiewe oorsake.

Hoe dikwels kom PFAPA-koors voor?

PFAPA-koors herhaal gewoonlik ongeveer elke 2–8 weke, en individuele aanvalle duur gewoonlik 3–7 dae. Sommige kinders het baie gereelde siklusse, terwyl ander wisselende tussenposes het. Kortikosteroïedbehandeling kan die tyd tot die volgende episode verkort, daarom hoort die tydstip van medikasie in die koorsdagboek. ’n Aanhoudende koors of die onvermoë om tussen aanvalle gesond te word, vereis ’n herevaluering eerder as om te aanvaar dat dit by PFAPA pas.

Kan ’n hoë CRP-bloedtoets PFAPA diagnoseer?

’n Hoë CRP-uitslag kan nie PFAPA diagnoseer nie, omdat infeksies en ander inflammatoriese afwykings dieselfde toename kan veroorsaak. Byvoorbeeld, ’n CRP van 80 mg/L tydens koors en 3 mg/L ná herstel dui op episodiese inflammasie, maar identifiseer nie die oorsaak daarvan nie. Baie laboratoriums gebruik ’n boonste CRP-verwysingsgrens van ongeveer 5 mg/L, terwyl sommige 10 mg/L gebruik. Klinici interpreteer die uitslag saam met simptome, ondersoekbevindinge, die tydsberekening van die monsterafname en enige relevante infeksietoetse.

Is PFAPA aansteeklik, en benodig dit antibiotika?

PFAPA self is nie aansteeklik nie, en antibiotika behandel nie die onderliggende inflammatoriese proses nie. ’n Tipiese aanval van 3–7 dae kan vanself eindig nadat ’n antibiotikum begin is, wat die misleidende indruk skep dat die antibiotikum gewerk het. Kinders met PFAPA kan steeds aansteeklike virussiektes of bakteriële infeksies opdoen. ’n Nuwe koors met ander simptome, kontak met siek mense of ’n bevestigde bakteriële oorsaak moet op eie meriete beoordeel en behandel word.

Bewys ’n vinnige reaksie op prednisoon PFAPA?

’n Vinnige reaksie op voorgeskrewe prednisoon of prednisoloon ondersteun PFAPA, maar bewys nie die diagnose nie. Gepubliseerde PFAPA-behandelingsregimes sluit 0,5–2 mg/kg in, met die werklike dosis en maksimum dosis wat deur die behandelende klinikus bepaal word. Kortikosteroïede kan simptome van ander toestande onderdruk en kan die tyd tot die volgende PFAPA-aanval verkort. Gesinne moet ’n skriftelike behandelingsplan gebruik en ’n beoordeling aanvra voordat behandeling begin word wanneer ’n episode buitengewoon ernstig of anders is.

Wanneer moet ’n kind met vermoedelike PFAPA dringende mediese sorg ontvang?

’n Kind met vermoedelike PFAPA het noodsorg nodig vir koors met asemhalingsprobleme, verminderde reaksie, ’n stywe nek, ’n uitslag wat nie verbleik wanneer daarop gedruk word nie, of ernstige dehidrasie. Enige baba jonger as 3 maande met ’n temperatuur van 38°C of hoër moet dringend medies beoordeel word. Koors wat 5 dae of langer aanhou, regverdig ook ’n spoedige ondersoek, veral as dit met rooi oë, uitslag, gebarste lippe of geswelde hande en voete gepaardgaan. ’n Vorige PFAPA-diagnose beteken nie dat dit veilig is om ’n nuwe siekte met ander simptome te ignoreer nie.

Kry verduideliking van jou bloedtoets resultate

Laai jou laboratoriumverslag op en Kantesti se KI verduidelik elke biomerker binne sekondes in verstaanbare taal. Meer as 2 miljoen mense wêreldwyd gebruik dit.

Verwysings

  1. Klein, T., Mitchell, S., & Weber, H. (2026). aPTT-normaalreeks: D-dimeer, Proteïen C-gids vir bloedstolling. Kantesti KI-mediese navorsing. DOI
  2. Klein, T., Mitchell, S., & Weber, H. (2026). Gids vir serumproteïene: Globuliene, albumien en A/G-verhouding-bloedtoets. Kantesti KI-mediese navorsing. DOI
  3. Wang A et al. (2021). Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: A review. World Journal of Otorhinolaryngology - Head and Neck Surgery. DOI
  4. Vanoni F et al. (2016). PFAPA syndrome: a review on treatment and outcome. Pediatric Rheumatology. DOI
  5. Burton MJ et al. (2019). Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA). Cochrane Database of Systematic Reviews. DOI
  • 2M+Ontleedde toetse
  • 127+Lande
  • 100+Tale

Oor die mediese span

prof dr thomas klein hoof mediese beampte cmo kantesti ai

Thomas Klein, MD

Hoofouteur · Mediese beoordelaar

Hoof Mediese Beampte, Kantesti AI

Dr. Thomas Klein is ’n raadgesertifiseerde kliniese hematoloog en internis met meer as 15 jaar se ervaring in laboratoriumgeneeskunde en KI-ondersteunde kliniese ontleding.

dr. Sarah Mitchell hoof mediese adviseur kliniese patologie

Sarah Mitchell, MD, PhD

Mediese Adviseur

Hoof Mediese Adviseur - Kliniese Patologie & Interne Geneeskunde

Dr. Sarah Mitchell is ’n raad-gesertifiseerde kliniese patoloog met meer as 18 jaar se ondervinding in laboratoriumgeneeskunde en diagnostiese analise. Sy het spesialissertifisering in kliniese chemie en het uitgebreid gepubliseer oor biomerkerpanele en laboratoriumanalise in kliniese praktyk.

prof. Hans Weber senior mediese adviseur laboratoriumgeneeskunde

Prof. Dr. Hans Weber, PhD

Bydraende Deskundige

Professor in Laboratoriumgeneeskunde en Kliniese Biochemie

Prof. Dr. Hans Weber bring 30+ jaar se kundigheid in kliniese biochemie, laboratoriumgeneeskunde en biomarker-navorsing. Voormalige President van die Duitse Vereniging vir Kliniese Chemie, spesialiseer hy in diagnostiese paneelanalise, biomarker-standaardisering en KI-ondersteunde laboratoriumgeneeskunde.

E-E-A-T Vertrouenseine

Ervaring

Kliniese oorsig gelei deur ’n geneesheer van laboratorium-interpretasie-werksvloei.

Kundigheid

Laboratoriumgeneeskunde fokus op hoe biomerkers in ’n kliniese konteks optree.

Gesagsvermoë

Medies beoordeel deur Dr. Thomas Klein, met bydraes van Dr. Sarah Mitchell en Prof. Dr. Hans Weber.

Betroubaarheid

Bewysgebaseerde interpretasie met duidelike opvolgpaaie om alarm te verminder.

Mediese vrywaring

Hierdie artikel is slegs vir opvoedkundige doeleindes en vorm nie mediese advies nie. Raadpleeg altyd ’n gekwalifiseerde gesondheidsorgverskaffer vir besluite oor diagnose en behandeling.

Gepubliseer · Kontak die redaksiespan

Gepubliseer deur Kantesti Ltd, geregistreer in Engeland en Wallis, maatskappynr. 17090423, Londen, Verenigde Koninkryk.

Deur Prof. Dr. Thomas Klein

Dr. Thomas Klein is ’n raad-gesertifiseerde kliniese hematoloog wat as Hoof Mediese Beampte by Kantesti AI dien. Met meer as 15 jaar se ondervinding in laboratoriumgeneeskunde en ’n sterk belangstelling in KI-ondersteunde interpretasie van bloedtoets resultate, werk hy daaraan om nuwe tegnologie met alledaagse kliniese praktyk te verbind. Sy belangstellings sluit in biomerkeraanalisering, kliniese besluitsteun-navorsing en optimalisering van populasie-spesifieke verwysingsreekse. As HMB lewer hy kliniese insette tot die platform se interne maatstawwe en verskaf hy kliniese toesig vir die mediese gehalte van Kantesti se opvoedkundige verslae.

Maak 'n opvolg-bydrae

Jou e-posadres sal nie gepubliseer word nie. Verpligte velde word met * aangedui